English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

To the Editor  I deeply regret to inform you and request for retraction of our review paper published in YMJ.1  We have applied for the U.S. patent with some ideas and research data which are related to the review paper. Upon request from a patent lawyer's office, we checked the references used in our paper for the Information Disclosure Statement (IDS). We realized that our review paper plagiarized several sentences from a previously published review paper titled as "The biochemical and biological functions of human papillomavirus type 16 E5 protein" in Arch Virol (2003;148:1445-53). As a corresponding author, I will take full responsibility and respectfully request for the retraction of our review paper from YMJ.

Retraction: Human Papillomavirus Type 16 E5 Protein as a Therapeutic Target. Yonsei Med J 2006;47(1):1-14